Algernon Announces Increase to Private Placement Financing to $750,000 and Close of Third Tranche
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 23, 2025 (GLOBE NEWSWIRE) — Algernon Health Inc. (the "Company" or "Algernon") (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian h
(Financial Post, 2025-12-23T21:03:58Z)